Mellman I, Coukos G, Dranoff G. Cancer immunotherapies comes of age. Nature 2011; 480: 480.
Sistigu A, Viaud S, Chaput N, et al. Immunomodulatory effects of cyclophosphamide and implementations for vaccine design. Semin Immunopathol 2011; 33: 369.
Suzuki E, Kapoor V, Jassar AS, et al. Gemcitabine selectively eliminates splenic Gr-1+/CD11b+ myeloid suppressor cells in tumor-bearing animals and enhances antitumor immune activity. Clin Cancer Res 2005; 11: 6713.
Tongu M, Harashima N, Monma H, et al. Metronomic chemotherapy with low-dose cyclophophamide plus gemcitabine can induce anti-tumor T cell immunity in vivo. Cancer Immunol Immunother 2013; 62: 383.
Kurose K, Ohue Y, Wada H, et al. Phase Ia study of Foxp3+ CD4 Treg depletion by infusion of a humanized anti-CCR 4 antibody, KW-0761, in cancer patients. Clin Cancer Res 2015; 21: 4327.